JP2005529084A5 - - Google Patents

Download PDF

Info

Publication number
JP2005529084A5
JP2005529084A5 JP2003576414A JP2003576414A JP2005529084A5 JP 2005529084 A5 JP2005529084 A5 JP 2005529084A5 JP 2003576414 A JP2003576414 A JP 2003576414A JP 2003576414 A JP2003576414 A JP 2003576414A JP 2005529084 A5 JP2005529084 A5 JP 2005529084A5
Authority
JP
Japan
Prior art keywords
parecoxib sodium
drug substance
anhydrous
parecoxib
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003576414A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005529084A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/007484 external-priority patent/WO2003078408A1/en
Publication of JP2005529084A publication Critical patent/JP2005529084A/ja
Publication of JP2005529084A5 publication Critical patent/JP2005529084A5/ja
Pending legal-status Critical Current

Links

JP2003576414A 2002-03-15 2003-03-12 結晶性パレコキシブナトリウム Pending JP2005529084A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36456702P 2002-03-15 2002-03-15
US41798702P 2002-10-11 2002-10-11
PCT/US2003/007484 WO2003078408A1 (en) 2002-03-15 2003-03-12 Crystalline parecoxib sodium

Publications (2)

Publication Number Publication Date
JP2005529084A JP2005529084A (ja) 2005-09-29
JP2005529084A5 true JP2005529084A5 (enExample) 2006-04-27

Family

ID=28045416

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003576414A Pending JP2005529084A (ja) 2002-03-15 2003-03-12 結晶性パレコキシブナトリウム

Country Status (18)

Country Link
US (1) US20030232871A1 (enExample)
EP (1) EP1485362A1 (enExample)
JP (1) JP2005529084A (enExample)
KR (1) KR100763045B1 (enExample)
CN (1) CN1642926A (enExample)
AR (1) AR038985A1 (enExample)
AU (1) AU2003220180A1 (enExample)
BR (1) BR0308431A (enExample)
CA (1) CA2478500A1 (enExample)
CO (1) CO5631437A2 (enExample)
IL (1) IL163780A0 (enExample)
MX (1) MXPA04008932A (enExample)
MY (1) MY148518A (enExample)
NZ (1) NZ535951A (enExample)
PL (1) PL372880A1 (enExample)
RU (1) RU2300529C2 (enExample)
TW (1) TW200400949A (enExample)
WO (1) WO2003078408A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050143431A1 (en) * 2003-04-04 2005-06-30 Hetero Drugs Limited Novel crystalline forms of parecoxib sodium
WO2005032556A1 (en) 2003-10-02 2005-04-14 Elan Pharmaceuticals, Inc. Method for reducing pain
BRPI0417197A (pt) * 2003-12-24 2007-03-06 Pharmacia Corp sais de metais de parecoxib como pró-drogas do inibidor de cox-2 valdecoxib para tratamento de inflamação, dor e/ou febre
ITMI20040019A1 (it) * 2004-01-12 2004-04-12 Univ Bari Derivati isossazolici e loro impiego come inibitori della ciclossigenasi
US7796785B2 (en) * 2005-03-03 2010-09-14 Fujifilm Corporation Image extracting apparatus, image extracting method, and image extracting program
US20080108664A1 (en) 2005-12-23 2008-05-08 Liu Belle B Solid-state form of AMG 706 and pharmaceutical compositions thereof
US7989450B2 (en) 2008-01-11 2011-08-02 Universita' Degli Studi Di Bari Functionalized diarylisoxazoles inhibitors of ciclooxygenase
GB0919757D0 (en) * 2009-11-12 2009-12-30 Johnson Matthey Plc Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs
US8299295B2 (en) 2009-10-15 2012-10-30 Johnson Matthey Public Limited Company Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs
CN105726496B (zh) * 2014-12-12 2019-05-28 湖南科伦药物研究有限公司 一种帕瑞昔布钠冻干粉剂、其制备方法及其粉剂产品
CN105125506A (zh) * 2015-08-18 2015-12-09 上海秀新臣邦医药科技有限公司 一种注射用帕瑞昔布钠及其制备方法
CN106580893A (zh) * 2016-12-26 2017-04-26 上药东英(江苏)药业有限公司 一种帕瑞昔布钠冻干粉针制剂
CN106692079A (zh) * 2016-12-26 2017-05-24 上药东英(江苏)药业有限公司 一种帕瑞昔布钠长效冻干粉针制剂
CN117003769B (zh) * 2023-07-11 2024-11-22 中国科学院宁波材料技术与工程研究所 氯诺昔康复合物、氯诺昔康-小檗碱共晶及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9708574A (pt) * 1996-04-12 1999-08-03 Searle & Co Derivados benzeno sulfonamida substituídos como pródrogas de inibidores cox-2
EP1977749A1 (en) * 1996-10-15 2008-10-08 G.D. Searle LLC Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
MY137736A (en) * 2001-04-03 2009-03-31 Pharmacia Corp Reconstitutable parenteral composition
CA2462297C (en) * 2001-10-02 2009-04-07 Pharmacia Corporation Method for preparing benzenesulfonyl compounds

Similar Documents

Publication Publication Date Title
JP2005529084A5 (enExample)
JP2009534373A5 (enExample)
JP2021119136A5 (enExample)
CN101573368B (zh) 结晶型1-(β-D-吡喃葡糖基)-4-甲基-3-[5-(4-氟苯基)-2-噻吩基甲基]苯半水合物
ES2351958T3 (es) 5-cloro-3-(4-metanosulfonilfenil)-6'-metil-[2,3'] bipiridinil en forma cristalina pura y procedimiento de síntesis.
HRP20120007T1 (hr) Polimorfni oblik 4-[3-(4-ciklopropankarbonil-piperazin-1-karbonil)-4-fluoro-benzil]-2h-ftalazin-1-ona
ES2622356T3 (es) Formas cristalinas de tigeciclina y procesos para su preparación
ES2460919T3 (es) Formas polimórficas de p-hidroxibenzoato de (2S)-(4E)-N-metil-5-[3-(5-isopropoxipiridin)il]-4-penten-2-amonio para el tratamiento de trastornos del sistema nervioso central
HRP20231533T1 (hr) Kristalni oblici od (s)-1-(4-fluorofenil)-1-(2-(4-(6-(1-metil-1h-pirazol-4-il)pirolo[2,1-f][1,2,4 ]triazin-4-il)piperazinil)-pirimidin-5-il)etan-1-amina i postupci priprave
JP2005501074A (ja) パロキセチン・グリチルリチン酸塩
JP2008513358A5 (enExample)
WO2011143872A9 (zh) 一种(s)-4-羟基-2-氧代-1-吡咯烷乙酰胺晶型及其制备方法和用途
JP2016503010A5 (enExample)
RU2007109598A (ru) Кристаллическая форма бифенильного соединения
JP2010514725A5 (enExample)
Zhang et al. New polymorphs of Huperzine A: preparation, structures, and physicochemical properties of anhydrous crystal forms
TW202200594A (zh) 一種glp-1受體激動劑的晶型a及其製備方法
JP2020536893A5 (enExample)
RU2004127585A (ru) Кристаллическая натриевая соль парекоксиба
RU2009124113A (ru) Кристаллические формы glyt1
CN111278808B (zh) 2-(5-(4-(2-吗啉代乙氧基)苯基)吡啶-2-基)-n-苄基乙酰胺的固体形式
WO2005085199A1 (en) Novel polymorphs of etoricoxib
CN103755723B (zh) 一种利福平i晶型的制备方法
JP2004517088A5 (enExample)
TW200400043A (en) A process for the preparation of piroxicam: β -cyclodextrin inclusion compounds